Prolactin signaling mechanisms in ovary

Molecular and Cellular Endocrinology

Volumn 356, Issue 1-2, 2012, Pages 80-87

  Bouilly, Justine ^a,b   Sonigo, Charlotte ^a,b   Auffret, Julien ^a,b   Gibori, Geula ^c   Binart, Nadine ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Female; Isoform; Prolactin; Receptor

Indexed keywords

DUDP1 PROTEIN; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GROWTH HORMONE RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PROLACTIN; PROLACTIN RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR GALT; UNCLASSIFIED DRUG;

DIMERIZATION; FERTILITY; GALACTOSEMIA; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS; HYPOTHALAMUS; INFERTILITY; INTERNALIZATION; INTRACELLULAR SIGNALING; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; UBIQUITINATION;

ANIMALS; FEMALE; FERTILITY; HUMANS; OVARY; PROLACTIN; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN MULTIMERIZATION; PROTEOLYSIS; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION;

EID: 84859640536     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.05.004     Document Type: Review

References (92)

1. Albarracin C.T., Parmer T.G., Duan W.R., Nelson S.E., Gibori G. Identification of a major prolactin-regulated protein as 20 alpha-hydroxysteroid dehydrogenase: coordinate regulation of its activity, protein content, and messenger ribonucleic acid expression. Endocrinology 1994, 134:2453-2460.
2. Ali S., Chen Z., Lebrun J.J., Vogel W., Kharitonenkov A., Kelly P.A., Ullrich A. PTP1D is a positive regulator of the prolactin signal leading to b-casein promoter activation. EMBO J. 1996, 15:135-142.
3. Bachelot A., Beaufaron J., Servel N., Kedzia C., Monget P., Kelly P.A., Gibori G., Binart N. Prolactin independent rescue of mouse corpus luteum life span: identification of prolactin and luteinizing hormone target genes. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E676-E684.
4. Bachelot A., Binart N. Corpus luteum development: lessons from genetic models in mice. Curr. Top. Dev. Biol. 2005, 68:49-84.
5. Bachelot A., Binart N. Reproductive role of prolactin. Reproduction 2007, 133:361-369.
6. Bachelot A., Bouilly J., Liu Y., Rebourcet D., Leux C., Kuttenn F., Touraine P., Binart N. Sequence variation analysis of the prolactin receptor C-terminal region in women with premature ovarian failure. Fertil. Steril. 2010, 94:2772-2775.
7. Ben Jonathan N., Lapensee C.R., Lapensee E.W. What can we learn from rodents about prolactin in humans?. Endocr. Rev. 2008, 29:1-41.
8. Ben-Jonathan N., Mershon J.L., Allen D.L., Steinmetz R.W. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr. Rev. 1996, 17:639-669.
9. Berlanga J.J., Garcia-Ruiz J.P., Perrot-Applanat M., Kelly P.A., Edery M. The short form of the prolactin receptor silences prolactin induction of the b-casein gene promoter. Mol. Endocrinol. 1997, 11:1449-1457.
10. Berlanga J.J., Gualillo O., Buteau H., Applanat M., Kelly P.A., Edery M. Prolactin activates tyrosyl phosphorylation of insulin receptor substrate-1 and phosphatidylinositol-3-OH kinase. J. Biol. Chem. 1997, 272:2050-2052.
11. Biener E., Martin C., Daniel N., Frank S.J., Centonze V.E., Herman B., Djiane J., Gertler A. Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer microscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3. Endocrinology 2003, 144:3532-3540.
12. Binart N., Helloco C., Ormandy C.J., Barra J., Clement-Lacroix P., Baran N., Kelly P.A. Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology 2000, 141:2691-2697.
13. Binart N., Imbert-Bollore P., Baran N., Viglietta C., Kelly P.A. A short form of the prolactin receptor is able to rescue mammopoiesis in heterozygous prolactin receptor mice. Mol. Endocrinol. 2003, 17:1066-1074.
14. Binart N., Melaine N., Pineau C., Kercret H., Touzalin A.M., Imbert-Bollore P., Kelly P.A., Jegou B. Male reproductive function is not affected in prolactin receptor-deficient mice. Endocrinology 2003, 144:3779-3782.
15. Bole-Feysot C., Goffin V., Edery M., Binart N., Kelly P.A. Prolactin and its receptor: actions, signal transduction pathways and phenotypes observed in prolactin receptor knockout mice. Endocr. Rev. 1998, 19:225-268.
16. Bouchard P., Lagoguey M., Brailly S., Schaison G. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. J. Clin. Endocrinol. Metab. 1985, 60:258-262.
17. Brockman J.L., Schroeder M.D., Schuler L.A. PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. Mol. Endocrinol. 2002, 16:774-784.
18. Brown R.J., Adams J.J., Pelekanos R.A., Wan Y., McKinstry W.J., Palethorpe K., Seeber R.M., Monks T.A., Eidne K.A., Parker M.W., Waters M.J. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat. Struct. Mol. Biol. 2005, 12:814-821.
19. Castrillon D.H., Miao L., Kollipara R., Horner J.W., DePinho R.A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 2003, 301:215-218.
20. Chan C.B., Liu X., Ensslin M.A., Dillehay D.L., Ormandy C.J., Sohn P., Serra R., Ye K. PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. EMBO J. 2010, 29:956-968.
21. Clevenger C.V. Roles and regulation of stat family transcription factors in human breast cancer. Am. J. Pathol. 2004, 165:1449-1460.
22. Clevenger C.V., Furth P.A., Hankinson S.E., Schuler L.A. The role of prolactin in mammary carcinoma. Endocr. Rev. 2003, 24:1-27.
23. Clevenger C.V., Gadd S.L., Zheng J. New mechanisms for PRLr action in breast cancer. Trends Endocrinol. Metab. 2009, 20:223-229.
24. Davis J.A., Linzer D.H. Expression of multiple forms of the prolactin receptor. Mol. Endocrinol. 1989, 3:674-680.
25. Demaria J.E., Lerant A.A., Freeman M.E. Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats. Brain Res. 1999, 837:236-241.
26. Devi Y.S., Seibold A.M., Shehu A., Maizels E., Halperin J., Le J., Binart N., Bao L., Gibori G. Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. J. Biol. Chem. 2011, 286:7609-7618.
27. Devi Y.S., Shehu A., Stocco C., Halperin J., Le J., Seibold A.M., Lahav M., Binart N., Gibori G. Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor. Endocrinology 2009, 150:3327-3335.
28. Devoto, L., Kohen, P., Munoz, A., and Strauss, J.F., III, 2009. Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation. Reprod. Biomed. Online 18(Suppl. 2), 19-24.
29. Dombrowicz D., Sente B., Closset J., Hennen G. Dose-dependent effects of human prolactin on the immature hypophysectomized rat testis. Endocrinology 1992, 130:695-700.
30. Edson M.A., Nagaraja A.K., Matzuk M.M. The mammalian ovary from genesis to revelation. Endocr. Rev. 2009, 30:624-712.
31. Fan H.Y., Liu Z., Shimada M., Sterneck E., Johnson P.F., Hedrick S.M., Richards J.S. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 2009, 324:938-941.
32. Forges T., Monnier-Barbarino P., Leheup B., Jouvet P. Pathophysiology of impaired ovarian function in galactosaemia. Hum. Reprod. Update 2006, 12:573-584.
33. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 2000, 80:1523-1631.
34. Gadd S.L., Clevenger C.V. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol. Endocrinol. 2006, 11:2734-2746.
35. Gafvels M., Bjurulf E., Selstam G. Prolactin stimulates the expression of luteinizing hormone/chorionic gonadotropin receptor messenger ribonucleic acid in the rat corpus luteum and rescues early pregnancy from bromocriptine-induced abortion. Biol. Reprod. 1992, 47:534-540.
36. Gaytan F., Gaytan M., Castellano J.M., Romero M., Roa J., Aparicio B., Garrido N., Sanchez-Criado J.E., Millar R.P., Pellicer A., Fraser H.M., Tena-Sempere M. KiSS-1 in the mammalian ovary: distribution of kisspeptin in human and marmoset and alterations in KiSS-1 mRNA levels in a rat model of ovulatory dysfunction. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E520-E531.
37. Gertler A., Grosclaude J., Strasburger C.J., Nir S., Djiane J. Real-time kinetic measurements of the interactions between lactogenic hormones and prolactin-receptor extracellular domains from several species support the model of hormone-induced transient receptor dimerization. J. Biol. Chem. 1996, 271:24482-24491.
38. Gibori G., Richards J.S. Dissociation of two distinct luteotropic effects of prolactin: regulation of luteinizing hormone-receptor content and progesterone secretion during pregnancy. Endocrinology 1978, 102:767-774.
39. Goffin V., Binart N., Touraine P., Kelly P.A. Prolactin: the new biology of an old hormone. Annu. Rev. Physiol. 2002, 64:47-67.
40. Grattan D.R., Kokay I.C. Prolactin: a pleiotropic neuroendocrine hormone. J. Neuroendocrinol. 2008, 20:752-763.
41. Grosdemouge I., Bachelot A., Lucas A., Baran N., Kelly P.A., Binart N. Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod. Biol. Endocrinol. 2003, 1:1-12.
42. Gunnet J.W., Freeman M.E. The mating-induced release of prolactin: a unique neuroendocrine response. Endocrinol. Rev. 1983, 4:44-61.
43. Gunnet J.W., Freeman M.E. Hypothalamic regulation of mating-induced prolactin release. Effect of electrical stimulation of the medial preoptic area in conscious female rats. Neuroendocrinology 1984, 38:12-16.
44. Halperin J., Devi S.Y., Elizur S., Stocco C., Shehu A., Rebourcet D., Unterman T.G., Leslie N.D., Le J., Binart N., Gibori G. Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and Its target gene galt causing a severe ovarian defect. Mol. Endocrinol. 2008, 22:513-522.
45. Herman A., Bignon C., Daniel N., Grosclaude J., Gertler A., Djiane J. Functional heterodimerization of prolactin and growth hormone receptors by ovine placental lactogen. J. Biol. Chem. 2000, 275:6295-6301.
46. Horseman N.D., Zhao W., Montecino-Rodriguez E., Tanaka M., Nakashima K., Engle S.J., Smith F., Markoff E., Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997, 16:6926-6935.
47. Hosaka T., Biggs W.H., Tieu D., Boyer A.D., Varki N.M., Cavenee W.K., Arden K.C. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA 2004, 101:2975-2980.
48. Hu Z.Z., Meng J., Dufau M.L. Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J. Biol. Chem. 2001, 276:41086-41094.
49. Hugo E.R., Brandebourg T.D., Comstock C.E., Gersin K.S., Sussman J.J., Ben Jonathan N. LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology 2006, 147:306-313.
50. Jagarlamudi K., Reddy P., Adhikari D., Liu K. Genetically modified mouse models for premature ovarian failure (POF). Mol. Cell Endocrinol. 2010, 315:1-10.
51. Kline J.B., Clevenger C.V. Identification and characterization of the prolactin-binding protein in human serum and milk. J. Biol. Chem. 2001, 276:24760-24766.
52. Kline J.B., Roehrs H., Clevenger C.V. Functional characterization of the intermediate isoform of the human prolactin receptor. J. Biol. Chem. 1999, 274:35461-35468.
53. Kokay I.C., Petersen S.L., Grattan D.R. Identification of prolactin-sensitive GABA and Kisspeptin neurons in regions of the rat hypothalamus involved in the control of fertility. Endocrinology 2011, 152:526-535.
54. Kossiakoff A.A. The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors. Adv. Protein Chem. 2004, 68:147-169.
55. Kulkarni M.V., Tettamanzi M.C., Murphy J.W., Keeler C., Myszka D.G., Chayen N.E., Lolis E.J., Hodsdon M.E. Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation. J. Biol. Chem. 2010, 285:38524-38533.
56. Langenheim J.F., Chen W.Y. Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor. J. Recept. Signal. Transduct. Res. 2009, 29:107-112.
57. Lesueur L., Edery M., Ali S., Paly J., Kelly P.A., Djiane J. Comparison of long and short forms of the prolactin receptor on prolactin induced milk protein gene transcription. Proc. Natl. Acad. Sci. USA 1991, 88:824-828.
58. Li Y., Kumar K.G., Tang W., Spiegelman V.S., Fuchs S.Y. Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase. Mol. Cell Biol. 2004, 24:4038-4048.
59. Liu G., Hale G.E., Hughes C.L. Galactose metabolism and ovarian toxicity. Reprod. Toxicol. 2000, 14:377-384.
60. Lucas B.K., Ormandy C., Binart N., Bridges R.S., Kelly P.A. Null mutation of prolactin receptor gene produces a defect in maternal behavior. Endocrinology 1998, 139:4102-4107.
61. Ma L., Gao J.S., Guan Y., Shi X., Zhang H., Ayrapetov M.K., Zhang Z., Xu L., Hyun Y.M., Kim M., Zhuang S., Chin Y.E. Acetylation modulates prolactin receptor dimerization. Proc. Natl. Acad. Sci. USA 2010, 107:19314-19319.
62. Nag S., Sanyal S., Ghosh K.K., Biswas N.M. Prolactin suppression and spermatogenic developments in maturing rats. A quantitative study. Horm. Res. 1981, 15:72-77.
63. Nagano M., Kelly P.A. Tissue distribution and regulation of rat prolactin receptor gene expression: quantitative analysis by polymerase chain reaction. J. Biol. Chem. 1994, 269:13337-13345.
64. Onuma H., Vander Kooi B.T., Boustead J.N., Oeser J.K., O'Brien R.M. Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin. Mol. Endocrinol. 2006, 20:2831-2847.
65. Ormandy C.J., Camus A., Barra J., Damotte D., Lucas B.K., Buteau H., Edery M., Brousse N., Babinet C., Binart N., Kelly P.A. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 1997, 11:167-178.
66. Palm I.F., van der Beek E.M., Swarts H.J., Van der Vilet J., Wiegant V.M., Buijs R.M., Kalsbeek A. Control of the estradiol-induced prolactin surge by the suprachiasmatic nucleus. Endocrinology 2001, 142:2296-2302.
67. Perks C.M., Newcomb P.V., Grohmann M., Wright R.J., Mason H.D., Holly J.M. Prolactin acts as a potent survival factor against C2-ceramide-induced apoptosis in human granulosa cells. Hum. Reprod. 2003, 18:2672-2677.
68. Perrot-Applanat M., Gualillo O., Pezet A., Vincent V., Edery M., Kelly P.A. Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol. Endocrinol. 1997, 11:1020-1032.
69. Pezet A., Ferrag F., Kelly P.A., Edery M. Tyrosine docking sites of the rat prolactin receptor required for association and activation of Stat5. J. Biol. Chem. 1997, 272:25043-25050.
70. Piquette G.N., LaPolt P.S., Oikawa M., Hsueh A.J. Regulation of luteinizing hormone receptor messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells. Endocrinology 1991, 128:2449-2456.
71. Prigent-Tessier A., Tessier C., Hirosawa-Takamori M., Boyer C., Ferguson-Gottschall S., Gibori G. Rat decidual prolactin. Identification, molecular cloning, and characterization. J. Biol. Chem. 1999, 274:37982-37989.
72. Purvis K., Clausen O.P., Olsen A., Haug E., Hansson V. Prolactin and Leydig cell responsiveness to LH/hCG in the rat. Arch. Androl. 1979, 3:219-230.
73. Qazi A.M., Tsai-Morris C.H., Dufau M.L. Ligand-independent homo- and hetero-dimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol. Endocrinol. 2006, 8:1912-1923.
74. Risk M., Gibori G. Mechanisms of luteal cell regulation by prolactin. Prolactin 2001, 265-295. Academic Publishers. N.D. Horseman (Ed.).
75. Russell D.L., Richards J.S. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells. Mol. Endocrinol. 1999, 13:2049-2064.
76. Saunier E., Dif F., Kelly P.A., Edery M. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology 2003, 144:2669-2675.
77. Schwarzler P., Untergasser G., Hermann M., Dirnhofer S., Abendstein B., Berger P. Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil. Steril. 1997, 68:696-701.
78. Segaloff D.L., Wang H.Y., Richards J.S. Hormonal regulation of luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian cells during follicular development and luteinization. Mol. Endocrinol. 1990, 4:1856-1865.
79. Shingo T., Gregg C., Enwere E., Fujikawa H., Hassam R., Geary C., Cross J.C., Weiss S. Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin. Science 2003, 299:117-120.
80. Soares M.J., Konno T., Alam S.M. The prolactin family: effectors of pregnancy-dependent adaptations. Trends Endocrinol. Metab. 2007, 18:114-121.
81. Stocco C., Telleria C., Gibori G. The Molecular Control of Corpus Luteum Formation, Function and Regression. Endocr. Rev. 2007, 28:117-149.
82. Stricker P., Grueter R. Action du lobe antérieur de l'hypophyse sur la montée laiteuse. C.R. Soc. Biol. 1928, 99:1978-1980.
83. Swaminathan G., Varghese B., Fuchs S.Y. Regulation of prolactin receptor levels and activity in breast cancer. J. Mammary. Gland. Biol. Neoplasia. 2008, 13:81-91.
84. Swaminathan G., Varghese B., Thangavel C., Carbone C.J., Plotnikov A., Kumar K.G., Jablonski E.M., Clevenger C.V., Goffin V., Deng L., Frank S.J., Fuchs S.Y. Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J. Endocrinol. 2008, 196:R1-R7.
85. Tan D., Johnson D.A., Wu W., Zeng L., Chen Y.H., Chen W.Y., Vonderhaar B.K., Walker A.M. Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells. Mol. Endocrinol. 2005, 19:1291-1303.
86. Tan D., Walker A.M. Short form 1b human prolactin receptor down-regulates expression of the long form. J. Mol. Endocrinol. 2010, 44:187-194.
87. Telleria C.M., Parmer T.G., Zhong L., Clarke D.L., Albarracin C.T., Duan W.R., Linzer D.I., Gibori G. The different forms of the prolactin receptor in the rat corpus luteum: developmental expression and hormonal regulation in pregnancy. Endocrinology 1997, 138:4812-4820.
88. Trott J.F., Hovey R.C., Koduri S., Vonderhaar B.K. Multiple new isoforms of the human prolactin receptor gene. Adv. Exp. Med. Biol. 2004, 554:495-499.
89. Varghese B., Barriere H., Carbone C.J., Banerjee A., Swaminathan G., Plotnikov A., Xu P., Peng J., Goffin V., Lukacs G.L., Fuchs S.Y. Polyubiquitination of prolactin receptor stimulates its internalization, postinternalization sorting, and degradation via the lysosomal pathway. Mol. Cell Biol. 2008, 28:5275-5287.
90. Vlahos N.P., Bugg E.M., Shamblott M.J., Phelps J.Y., Gearhart J.D., Zacur H.A. Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells. Mol. Hum. Reprod. 2001, 7:1033-1038.
91. Xu, J., Zhang, Y., Berry, P.A., Jiang, J., Lobie, P.E., Langenheim, J.F., Chen, W.Y., Frank, S.J., 2011. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. J. Clin. Endocrinol. Metab. 96, 872.
92. Zinaman M.J., Cartledge T., Tomai T., Tippett P., Merriam G.R. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women. J. Clin. Endocrinol. Metab. 1995, 80:2088-2093.